Results 101 to 110 of about 1,394,911 (165)

Sustained Complete Response to a Short Course of Subcutaneous Daratumumab in Multi-Refractory Immune Thrombocytopenia

A woman with primary immune thrombocytopenia (ITP) refractory to corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and two thrombopoietin receptor agonists (TPO-RAs) received a new therapy.
Tuba Gullu koca, Ahmet Mert Yanik
core   +1 more source

Ticlopidine Inhibits the Prothrombotic Effects of Thrombopoietin and Ameliorates Survival after Supralethal Total Body Irradiation

, 2002
SummaryThrombopoietin modulates the response of platelets to several agonists and, on the other hand, those agonists can be released following irradiation.
Gerard Wagemaker, Marc-André Mouthon, Marie Vandamme, Anne Van der Meeren, Marie-Hélène Gaugler, Patrick Gourmelon   +5 more
core   +1 more source

#100. Two True and Unrelated: Inpatient Evaluation for Severe Thrombocytopenia

Graduate Medical Education Research Journal
Mentor: Alex Nester Program: Internal Medicine & Pediatrics Type: Case Report Background: Understanding the etiology of thrombocytopenia in hospitalized patients is essential to effective management.
Audrey Lane, Alex Nester
doaj   +1 more source

Thrombopoietin receptor agonists in inherited thrombocytopenias: an evolving mosaic of evidence. [PDF]

Res Pract Thromb Haemost
Zaninetti C.
europepmc   +1 more source

A Review of Thrombopoietin Receptor Agonists and Subsequent Development of Thrombosis: Exploring a Hematologic Paradox. [PDF]

Cureus
Graifman G, Parekh R, C P RV, Nair A.
europepmc   +1 more source

2026 Korean expert recommendations for the use of thrombopoietin receptor agonists in severe aplastic anemia. [PDF]

Blood Res
Park S, Jang JH, Song IC, Ahn SY, Shin DY, Park Y, Mun YC.   +6 more
europepmc   +1 more source

Thrombopoietin Receptor Agonists for Thrombocytopenia Secondary to HER2-Targeted Antibody Drug Conjugates. [PDF]

Oncologist, 2023
Rainone M, Kasparian S, Nguyen T, Talwar N, Yuan Y, Mei M, Mortimer JE, Waisman JR, Patel N, Pullarkat V.   +9 more
europepmc   +1 more source

Effectiveness and Safety of Two Thrombopoietin Receptor Agonists: A Retrospective Cohort Study of Adults With Primary Immune Thrombocytopenia. [PDF]

Cureus
Lanza DG, Enciso LJ, Moncaleano LG, Rodríguez MA.   +3 more
europepmc   +1 more source

Efficacy and safety of thrombopoietin receptor agonists in solid tumors with chemotherapy-induced thrombocytopenia: a meta-analysis. [PDF]

BMC Pharmacol Toxicol, 2023
Chen W, Liu Y, Li L, Zeng X.
europepmc   +1 more source

Treatment patterns and safety outcomes after splenectomy or thrombopoietin receptor agonists as second-line therapy for immune thrombocytopenia: Korean claims-based study. [PDF]

Res Pract Thromb Haemost
Lim HJ, Kwak K, Kim C, Choi YS, Park Y, Kim BS, Ahn KH, Kang KW.   +7 more
europepmc   +1 more source